Sfoglia per Autore
Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer
2011-01-01 Tiseo, M.; Gelsomino, F.; Bartolotti, M.; Bordi, P.; Bersanelli, Melissa; Rossi, G.; Ardizzoni, A.
Capter 4 - Adjuvant Therapy for Renal Cell Carcinoma
2012-01-01 Buti, S; Bersanelli, M; Donini, M; Ardizzoni, A
Asymptomatic pulmonary embolism in lung cancer: Prevalence and analysis of clinical and radiological characteristics in 141 outpatients
2012-01-01 Tiseo, M.; Bersanelli, M.; Barili, M. P.; Bartolotti, M.; De Luca, G.; Gelsomino, F.; Camisa, R.; Cademartiri, F.; Ardizzoni, A.
Systemic adjuvant therapies in renal cell carcinoma
2012-01-01 Buti, S.; Bersanelli, M.; Donini, M.; Ardizzoni, A.
Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma
2012-01-01 Genestreti, G.; Moretti, A.; Piciucchi, S.; Tiseo, M.; Bersanelli, M.; Scarlattei, M.; Scarpi, E.; Dubini, A.; Matteucci, F.; Sanna, S.
Chemotherapy in metastatic renal cell carcinoma today? A systematic review
2013-01-01 Buti, S.; Bersanelli, M.; Sikokis, A.; Maines, F.; Facchinetti, F.; Bria, E.; Ardizzoni, A.; Tortora, G.; Massari, F.
Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy
2014-01-01 Bersanelli, M.; Buti, S.; Camisa, R.; Brighenti, M.; Lazzarelli, S.; Mazza, G.; Passalacqua, R.
Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis
2014-01-01 Bersanelli, M.; Tiseo, M.; Artioli, F.; Lucchi, L.; Ardizzoni, A.
BOLERO-3 results: Pharmacological activity or pharmacokinetic effect?
2014-01-01 Buti, S.; Bersanelli, M.; Tiseo, M.; Ardizzoni, A.; Musolino, A.
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy
2015-01-01 Santoni, M.; Buti, S.; Conti, A.; Porta, C.; Procopio, G.; Sternberg, C. N.; Bracarda, S.; Basso, U.; De Giorgi, U.; Rizzo, M.; Derosa, L.; Ortega, C.; Massari, F.; Milella, M.; Bersanelli, M.; Cerbone, L.; Muzzonigro, G.; Burattini, L.; Montironi, R.; Santini, D.; Cascinu, S.
Combination therapy in kidney cancer: The next revolution?
2015-01-01 Buti, S.; Bersanelli, M.
Retroperitoneal cystoadenocarcinoma: A case report with a literature review
2015-01-01 Zanoni, D.; Sikokis, A.; Bersanelli, M.; Gnetti, L.; Buti, S.
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review
2016-01-01 Pellegrino, B.; Sikokis, A.; Bersanelli, M.; Leonetti, A.; Leonardi, F.; Di Meglio, G.; Buti, S.
Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: A pooled analysis of 926 patients
2016-01-01 Van der Hulle, T.; den Exter, P. L.; Planquette, B.; Meyer, G.; Soler, S.; Monreal, M.; Jimenez, D.; Portillo, A. K.; O'Connell, C.; Liebman, H. A.; Shteinberg, M.; Adir, Y.; Tiseo, M.; Bersanelli, M.; Abdel-Razeq, H. N.; Mansour, A. H.; Donnelly, O. G.; Radhakrishna, G.; Ramasamy, S.; Bozas, G.; Maraveyas, A.; Shinagare, A. B.; Hatabu, H.; Nishino, M.; Huisman, M. V.; Klok, F. A.
Pazopanib in renal cell carcinoma dialysis patients: A mini-review and a case report
2016-01-01 Bersanelli, M.; Facchinetti, F.; Tiseo, M.; Maiorana, M.; Buti, S.
The 'nivolution' in renal cell carcinoma: Behind the scenes of clinical trials
2016-01-01 Buti, S.; Bersanelli, M.
Non-clear-cell renal carcinoma therapy: Handle with care
2016-01-01 Buti, S.; Bersanelli, M.
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Part 2 - Prostate and bladder cancer
2016-01-01 Buti, S.; Ciccarese, C.; Iacovelli, R.; Bersanelli, M.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.; Tortora, G.; Massari, F.
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review
2016-01-01 Leonetti, A.; Bersanelli, M.; Castagneto, B.; Masini, C.; Di Meglio, G.; Pellegrino, B.; Buti, S.
Everolimus in the management of metastatic renal cell carcinoma: An evidence-based review of its place in therapy
2016-01-01 Buti, S.; Leonetti, A.; Dallatomasina, A.; Bersanelli, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer | 1-gen-2011 | Tiseo, M.; Gelsomino, F.; Bartolotti, M.; Bordi, P.; Bersanelli, Melissa; Rossi, G.; Ardizzoni, A. | |
Capter 4 - Adjuvant Therapy for Renal Cell Carcinoma | 1-gen-2012 | Buti, S; Bersanelli, M; Donini, M; Ardizzoni, A | |
Asymptomatic pulmonary embolism in lung cancer: Prevalence and analysis of clinical and radiological characteristics in 141 outpatients | 1-gen-2012 | Tiseo, M.; Bersanelli, M.; Barili, M. P.; Bartolotti, M.; De Luca, G.; Gelsomino, F.; Camisa, R.; Cademartiri, F.; Ardizzoni, A. | |
Systemic adjuvant therapies in renal cell carcinoma | 1-gen-2012 | Buti, S.; Bersanelli, M.; Donini, M.; Ardizzoni, A. | |
Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma | 1-gen-2012 | Genestreti, G.; Moretti, A.; Piciucchi, S.; Tiseo, M.; Bersanelli, M.; Scarlattei, M.; Scarpi, E.; Dubini, A.; Matteucci, F.; Sanna, S. | |
Chemotherapy in metastatic renal cell carcinoma today? A systematic review | 1-gen-2013 | Buti, S.; Bersanelli, M.; Sikokis, A.; Maines, F.; Facchinetti, F.; Bria, E.; Ardizzoni, A.; Tortora, G.; Massari, F. | |
Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy | 1-gen-2014 | Bersanelli, M.; Buti, S.; Camisa, R.; Brighenti, M.; Lazzarelli, S.; Mazza, G.; Passalacqua, R. | |
Gefitinib and afatinib treatment in an advanced non-small cell lung cancer (NSCLC) patient undergoing hemodialysis | 1-gen-2014 | Bersanelli, M.; Tiseo, M.; Artioli, F.; Lucchi, L.; Ardizzoni, A. | |
BOLERO-3 results: Pharmacological activity or pharmacokinetic effect? | 1-gen-2014 | Buti, S.; Bersanelli, M.; Tiseo, M.; Ardizzoni, A.; Musolino, A. | |
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy | 1-gen-2015 | Santoni, M.; Buti, S.; Conti, A.; Porta, C.; Procopio, G.; Sternberg, C. N.; Bracarda, S.; Basso, U.; De Giorgi, U.; Rizzo, M.; Derosa, L.; Ortega, C.; Massari, F.; Milella, M.; Bersanelli, M.; Cerbone, L.; Muzzonigro, G.; Burattini, L.; Montironi, R.; Santini, D.; Cascinu, S. | |
Combination therapy in kidney cancer: The next revolution? | 1-gen-2015 | Buti, S.; Bersanelli, M. | |
Retroperitoneal cystoadenocarcinoma: A case report with a literature review | 1-gen-2015 | Zanoni, D.; Sikokis, A.; Bersanelli, M.; Gnetti, L.; Buti, S. | |
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review | 1-gen-2016 | Pellegrino, B.; Sikokis, A.; Bersanelli, M.; Leonetti, A.; Leonardi, F.; Di Meglio, G.; Buti, S. | |
Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: A pooled analysis of 926 patients | 1-gen-2016 | Van der Hulle, T.; den Exter, P. L.; Planquette, B.; Meyer, G.; Soler, S.; Monreal, M.; Jimenez, D.; Portillo, A. K.; O'Connell, C.; Liebman, H. A.; Shteinberg, M.; Adir, Y.; Tiseo, M.; Bersanelli, M.; Abdel-Razeq, H. N.; Mansour, A. H.; Donnelly, O. G.; Radhakrishna, G.; Ramasamy, S.; Bozas, G.; Maraveyas, A.; Shinagare, A. B.; Hatabu, H.; Nishino, M.; Huisman, M. V.; Klok, F. A. | |
Pazopanib in renal cell carcinoma dialysis patients: A mini-review and a case report | 1-gen-2016 | Bersanelli, M.; Facchinetti, F.; Tiseo, M.; Maiorana, M.; Buti, S. | |
The 'nivolution' in renal cell carcinoma: Behind the scenes of clinical trials | 1-gen-2016 | Buti, S.; Bersanelli, M. | |
Non-clear-cell renal carcinoma therapy: Handle with care | 1-gen-2016 | Buti, S.; Bersanelli, M. | |
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Part 2 - Prostate and bladder cancer | 1-gen-2016 | Buti, S.; Ciccarese, C.; Iacovelli, R.; Bersanelli, M.; Scarpelli, M.; Lopez-Beltran, A.; Cheng, L.; Montironi, R.; Tortora, G.; Massari, F. | |
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review | 1-gen-2016 | Leonetti, A.; Bersanelli, M.; Castagneto, B.; Masini, C.; Di Meglio, G.; Pellegrino, B.; Buti, S. | |
Everolimus in the management of metastatic renal cell carcinoma: An evidence-based review of its place in therapy | 1-gen-2016 | Buti, S.; Leonetti, A.; Dallatomasina, A.; Bersanelli, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile